Australia markets open in 8 hours 43 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
40.93-0.11 (-0.27%)
At close: 04:00PM EST
41.00 +0.07 (+0.17%)
Pre-market: 08:33AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 7.43B
Enterprise value 7.12B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)27.20
Enterprise value/revenue N/A
Enterprise value/EBITDA -17.93

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 354.22%
S&P500 52-week change 324.16%
52-week high 343.59
52-week low 319.59
50-day moving average 342.02
200-day moving average 330.72

Share statistics

Avg vol (3-month) 33M
Avg vol (10-day) 32.5M
Shares outstanding 5181.43M
Implied shares outstanding 6181.43M
Float 876.42M
% held by insiders 115.30%
% held by institutions 186.68%
Shares short (31 Jan 2024) 46.02M
Short ratio (31 Jan 2024) 43.65
Short % of float (31 Jan 2024) 46.99%
Short % of shares outstanding (31 Jan 2024) 43.32%
Shares short (prior month 29 Dec 2023) 44.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.08%
Return on equity (ttm)-89.69%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -409.53M
Net income avi to common (ttm)-392.99M
Diluted EPS (ttm)-2.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)676.88M
Total cash per share (mrq)3.76
Total debt (mrq)473.44M
Total debt/equity (mrq)173.45%
Current ratio (mrq)8.72
Book value per share (mrq)1.73

Cash flow statement

Operating cash flow (ttm)-332.36M
Levered free cash flow (ttm)-193.15M